Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

BullFrog Sale, Product Launches Warm Up Sun Care Sector

This article was originally published in The Tan Sheet

Executive Summary

Sun & Skin Care Research adds Chattem’s BullFrog to its portfolio encompassing the Ocean Potion, NO-AD and Margaritaville Parrot Head sunscreen brands. Also, Kiss My Face, L’Oreal’s La-Roche Posay brand, Expanscience Laboratories and JADS International extend their sun care lines.

You may also be interested in...



BullFrog Owner Maintains Masculine Heritage, Seeks Larger Footprint

“It is fun and more strongly skews toward male usage than virtually any other” sunscreen brand, says Sun & Skin Care Research executive VP Tom Nestor. Particularly popular among men, the line stands out in a category often purchased and used by women, Nestor notes.

BullFrog Owner Maintains Masculine Heritage, Seeks Larger Footprint

“It is fun and more strongly skews toward male usage than virtually any other” sunscreen brand, says Sun & Skin Care Research executive VP Tom Nestor. Particularly popular among men, the line stands out in a category often purchased and used by women, Nestor notes.

FDA Strengthens Sunscreen Testing And Label Requirements

As early as June 2012, sunscreens that fail “broad spectrum” tests or have an SPF less than 15 must warn that they have not been shown to prevent cancer or early skin aging, according to an FDA final rule.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS106244

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel